YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Aurobindo Pharma

Aurobindo Pharma

BSE: 524804|NSE: AUROPHARMA|ISIN: INE406A01037|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 26, 16:00
854.90
-8.25 (-0.96%)
VOLUME 220,441
LIVE
NSE
Feb 26, 15:58
855.20
-8.05 (-0.93%)
VOLUME 3,866,956
News on Aurobindo Pharma
Select Year: 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Aurobindo Pharma hopes to submit Phase 2/3 data of UB-612 COVID-19 vaccine by July 2021

7.30 pm | 19 Feb 2021 |  Source: Moneycontrol.com

Aurbindo has sought permission from Indian drug regulator CDSCO to conduct Phase-2/3 trial of the vaccine candidate in India, as the animal studies an...

Aurobindo Pharma gets USFDA nod for generic Droxidopa capsules

12.32 pm | 19 Feb 2021 |  Source: PTI

The approved product is a generic version of Lundbeck NA Ltd's Northera capsules....

Weekly Tactical Pick | Aurobindo Pharma

10.44 am | 19 Feb 2021 |  Source: Moneycontrol.com

Valuation at a discount to peers, but significant scope for margin improvement...

Buy Aurobindo Pharma; target of Rs 1100: Sharekhan

5.24 pm | 16 Feb 2021 |  Source: Moneycontrol.com

Sharekhan is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated February ...

Buy Aurobindo Pharma; target of Rs 1165: ICICI Direct

6.59 pm | 15 Feb 2021 |  Source: Moneycontrol.com

ICICI Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1165 in its research report dated Februa...

Aurobindo Pharma: Vaccine and API plans inject add-on growth levers

11.06 am | 12 Feb 2021 |  Source: Moneycontrol.com

In the injectables space, Aurobindo Pharma remains constructive and targets to almost double from current annual sales base of $380 million to ...

Aurobindo Pharm Standalone December 2020 Net Sales at Rs 3,710.86 crore, up 10.92% Y-o-Y

10.44 am | 11 Feb 2021 |  Source: Moneycontrol.com

NULL...

Aurobindo Pharm Consolidated December 2020 Net Sales at Rs 6,364.91 crore, up 7.97% Y-o-Y

10.44 am | 11 Feb 2021 |  Source: Moneycontrol.com

NULL...

Aurobindo Pharma Q3 net profit zooms over 4-fold to Rs 2,946.32 crore

10.20 pm | 10 Feb 2021 |  Source: PTI

The company had posted a net profit of Rs 705.31 crore in the corresponding period of the previous fiscal, Aurobindo Pharma said in a filing to BSE....

Budget 2021: Pharma sector sees higher spend on healthcare as positive, but some expectations remain unmet

6.18 pm | 02 Feb 2021 |  Source: Moneycontrol.com

The industry welcomes increased budgetary allocations but believes tax incentives would have encouraged investment in R&D and help position India as a...

Gland Pharma Q3: Strong and clean play on global generic injectables; accumulate

9.35 am | 25 Jan 2021 |  Source: Moneycontrol.com

We believe dominance of profit/royalty-sharing aspect in the business model distinguishes Gland Pharma from other contract manufacturers...

Aurobindo Pharma Q3 PAT seen up 17.2% YoY to Rs. 719 cr: Prabhudas Lilladher

10.47 pm | 18 Jan 2021 |  Source: Moneycontrol.com

Net Sales are expected to increase by 15.5 percent Y-o-Y (up 5 percent Q-o-Q) to Rs. 5,799.4 crore, according to Prabhudas Lilladher....

Buy Aurobindo Pharma: target of Rs 1024: Sharekhan

1.46 pm | 18 Dec 2020 |  Source: Moneycontrol.com

Sharekhan is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1024 in its research report dated December ...

Accumulate Aurobindo Pharma; target of Rs 921: Prabhudas Lilladher

1.57 pm | 18 Nov 2020 |  Source: Moneycontrol.com

Prabhudas Lilladher recommended accumulate rating on Aurobindo Pharma with a target price of Rs 921 in its research report dated November 12, 2020....

Buy Aurobindo Pharma; target of Rs 1025: ICICI Direct

11.22 am | 17 Nov 2020 |  Source: Moneycontrol.com

ICICI Direct is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 1025 in its research report dated November 1...

Buy Aurobindo Pharma; target of Rs 980: Motilal Oswal

11.56 am | 15 Nov 2020 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 980 in its research report dated November 1...

Buy Aurobindo Pharma: target of Rs 1024: Sharekhan

11.31 am | 15 Nov 2020 |  Source: Moneycontrol.com

Sharekhan is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 1024 in its research report dated November 12, ...

Aurobindo Pharma Q2 profit jumps 26% to Rs 805.6 crore; US business grows 12.5%

7.49 pm | 11 Nov 2020 |  Source: Moneycontrol.com

ARV revenue at Rs 502.7 crore increased 111.4 percent YoY and API revenue at Rs 829 crore rose 2.9 percent YoY for the quarter ended September 2020, t...

Buy Aurobindo Pharma; target of Rs 985: Motilal Oswal

1.19 pm | 28 Oct 2020 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 985 in its research report dated October 26...

Buy Aurobindo Pharma; target of Rs 1025: ICICI Direct

2.00 pm | 27 Oct 2020 |  Source: Moneycontrol.com

ICICI Direct is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 1025 in its research report dated October 26...

1 2
Quick Links for Aurobindo Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.